REVERSIBLE INHIBITION OF OSTEOCLASTIC ACTIVITY BY BONE-BOUND GALLIUM(III)

被引:39
作者
BLAIR, HC
TEITELBAUM, SL
TAN, HL
SCHLESINGER, PH
机构
[1] JEWISH HOSP ST LOUIS,DEPT PATHOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,MED CTR,DEPT PHYSIOL & CELL BIOL,ST LOUIS,MO 63110
关键词
BONE RESORPTION; OSTEOCLAST; GALLIUM; HYPERCALCEMIA; OSTEOPOROSIS;
D O I
10.1002/jcb.240480409
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gallium(III) is a new therapeutic agent for hypercalcemia. Ga3+ reduces osteoclast action, but how it inhibits the cell's physiology is unknown. In vivo, 7-12-mu-M Ga(III) reduces calcium release from bone, but surprisingly, 10-100-mu-M Ga3+ added to isolated avian osteoclasts did not reduce their degradation of L-(5-H-3)-proline bone. H-3-proline labels bone collagen specifically, and collagenolysis is an excellent indicator of bone dissolution because collagen is the least soluble component of bone. Ga(III) > 100-mu-M inhibited osteoclasts in vitro, but also killed the cells. To resolve this apparent conflict, we measured Ga-67 distribution between bone, cells, and media. Gallium binds avidly but slowly to bone fragments. One hundred micrograms of bone clears 60% of 1-mu-M gallium from 500-mu-l of tissue culture medium, with steady state at > 24 h. Osteoclasts on bone inhibited gallium binding capacity approximately 40%, indicating a difference in available binding area and suggesting that osteoclasts protect their substrate from Ga binding. Less gallium binds to bone in serum-containing medium than in phosphate-buffered saline; 30% reduction of the affinity constant suggests that the serum containing medium competes with bone binding. Consequently, the effect of [Ga] on bone degradation was studied using accurately controlled amounts of Ga(III) pre-bound to the bone. Under these conditions, gallium sensitivity of osteoclasts is striking. At 2 days, 100-mu-g of bone pre-incubated with 1 ml of 1-mu-M Ga3+, with 10 pmoles Ga3+/mu-g bone, was degraded at 50% the rate of control bone; over 50 pM Ga3+/mu-g bone, resorption was essentially zero. In contrast, pre-treatment of bone with [Ga3+] as high as 15-mu-M had no significant effect on bone resorption rate beyond 3 days, indicating that gallium below approximately 150 pg/mu-g bone acts for a limited time and does not permanently damage the cells. We conclude that bone-bound Ga(III) from medium concentrations < 15-mu-M inhibits osteoclasts reversibly, while irreversible toxicity occurs at solution [Ga3+] > 50-mu-M.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 15 条
  • [1] ISOLATED OSTEOCLASTS RESORB THE ORGANIC AND INORGANIC COMPONENTS OF BONE
    BLAIR, HC
    KAHN, AJ
    CROUCH, EC
    JEFFREY, JJ
    TEITELBAUM, SL
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 102 (04) : 1164 - 1172
  • [2] PASSIVE CHLORIDE PERMEABILITY CHARGE COUPLED TO H+-ATPASE OF AVIAN OSTEOCLAST RUFFLED MEMBRANE
    BLAIR, HC
    TEITELBAUM, SL
    TAN, HL
    KOZIOL, CM
    SCHLESINGER, PH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (06): : C1315 - C1324
  • [3] MICROMOLAR ALUMINUM LEVELS REDUCE THYMIDINE-H-3 INCORPORATION BY CELL-LINE UMR 106-01
    BLAIR, HC
    FINCH, JL
    AVIOLI, R
    CROUCH, EC
    SLATOPOLSKY, E
    TEITELBAUM, SL
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (05) : 1119 - 1125
  • [4] DISTRIBUTION OF TRACE LEVELS OF THERAPEUTIC GALLIUM IN BONE AS MAPPED BY SYNCHROTRON X-RAY MICROSCOPY
    BOCKMAN, RS
    REPO, MA
    WARRELL, RP
    POUNDS, JG
    SCHIDLOVSKY, G
    GORDON, BM
    JONES, KW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) : 4149 - 4153
  • [5] BISPHOSPHONATES DIRECTLY INHIBIT THE BONE-RESORPTION ACTIVITY OF ISOLATED AVIAN OSTEOCLASTS INVITRO
    CARANO, A
    TEITELBAUM, SL
    KONSEK, JD
    SCHLESINGER, PH
    BLAIR, HC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) : 456 - 461
  • [6] FOSTER BJ, 1986, CANCER TREAT REP, V70, P1311
  • [7] GALLIUM INHIBITS BONE-RESORPTION BY A DIRECT EFFECT ON OSTEOCLASTS
    HALL, TJ
    CHAMBERS, TJ
    [J]. BONE AND MINERAL, 1990, 8 (03): : 211 - 216
  • [8] LAKATOS P, 1991, J BONE MINER RES, V6, P1121
  • [9] LANGMUIR I, 1917, AM CHEM SOC J, V38, P2221
  • [10] MATROVIC V, 1990, LANCET, V335, P72